Quantcast

Vertex expands deal with NHS England to Include Kaftrio Kalydeco combo

As Vertex expands deal with NHS England to include Kaftrio in combination with Kalydeco, the cysitc fibrosis patients in England will be among the first in Europe to benefit from access to Kaftrio, if the medicine is approved by the European Commission.

Read more